EVMN vs EYPT

Evommune, Inc. vs EyePoint, Inc. — Valuation Comparison 2026

EVMN

Biotechnology
Evommune, Inc.
Quality
6.0
out of 10
Value Trap
Price
$23.33
Last close
Models
9/13
Active
VS

EYPT

Biotechnology
EyePoint, Inc.
Quality
5.6
out of 10
Value Trap
12
SAFE
Price
$13.50
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType EVMN Fair ValueEVMN Upside EYPT Fair ValueEYPT Upside
Bayesian DCF Intrinsic $3.93 -83.1% $4.03 -70.2%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $2.55 -89.6% $4.13 -69.4%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for EVMN vs EYPT — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

EVMN vs EYPT — Which Stock Is More Undervalued?

EVMN scores higher with a 6.0/10 quality rating vs EYPT's 5.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Evommune, Inc. (EVMN) and EyePoint, Inc. (EYPT) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

EVMN currently trades at $23.33 with a QOC of 6.0/10, while EYPT trades at $13.50 with a QOC of 5.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).